All News #Library
Biotech
Lilly Bets $2.6B on Korean Biotech`s Bispecific Antibodies
14 Nov 2025 //
PRESS RELEASE
ABL Bio Taps into Synaffix ADC Tech to Accelerate Development
04 Nov 2025 //
PR NEWSWIRE
ABL Bio, GSK partner on Brain Delivery Platform for Diseases
08 Apr 2025 //
PR NEWSWIRE
ABL Bio Announces Clinical Collaboration For ABL103 with Keytruda
04 Oct 2024 //
PR NEWSWIRE
Biocytogen Enters Collaboration with ABL Bio to Develop New Bispecific ADC
25 Mar 2024 //
BUSINESSWIRE
I-Mab and ABL Bio Announce Latest Updates of Antibody TJ-L14B/ABL503
10 Oct 2023 //
PR NEWSWIRE
ABL Bio Taps into Synaffix ADC Technology for Bispecific ADC Products
13 Sep 2023 //
PR NEWSWIRE

Market Place
Sourcing Support